These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3311684)

  • 1. Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents.
    Murray M
    Drug Metab Rev; 1987; 18(1):55-81. PubMed ID: 3311684
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach.
    Obach RS; Walsky RL; Venkatakrishnan K; Houston JB; Tremaine LM
    Clin Pharmacol Ther; 2005 Dec; 78(6):582-92. PubMed ID: 16338274
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Description of cytochrome p-450 research].
    Wang XL
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):233-7. PubMed ID: 6359412
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 8. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
    Hines RN; Prough RA
    J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
    Filimonova AA; Ziganshin AU; Ziganshina LE
    Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors regulating drug metabolism in intact hepatocytes.
    Thurman RG; Kauffman FC
    Pharmacol Rev; 1979 Dec; 31(4):229-51. PubMed ID: 399807
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug metabolism: prospects for the future.
    Leibman KC
    Drug Metab Rev; 1979; 10(2):299-309. PubMed ID: 121804
    [No Abstract]   [Full Text] [Related]  

  • 13. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.
    Crespi CL; Miller VP; Penman BW
    Anal Biochem; 1997 May; 248(1):188-90. PubMed ID: 9177742
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-drug interactions: how scared should we be?
    Shapiro LE; Shear NH
    CMAJ; 1999 Nov; 161(10):1266-7. PubMed ID: 10584089
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heritable polymorphisms in oxidative drug metabolism].
    Kallio J
    Duodecim; 1990; 106(5):408-14. PubMed ID: 1670108
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic factors in hepatic drug oxidation.
    Kalow W; Inaba T
    Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytochrome P-450 isoenzymes as predictors of drug interactions].
    Pelkonen O
    Duodecim; 1994; 110(17):1575-9. PubMed ID: 7497987
    [No Abstract]   [Full Text] [Related]  

  • 19. A basic conceptual and practical overview of interactions with highly prescribed drugs.
    Dresser GK; Bailey DG
    Can J Clin Pharmacol; 2002; 9(4):191-8. PubMed ID: 12584577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction.
    Gonzalez FJ
    NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.